Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines
Top Cited Papers
- 1 January 2008
- Vol. 26 (2) , 193-200
- https://doi.org/10.1016/j.vaccine.2007.10.064
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Phase 1 Study of Two Merozoite Surface Protein 1 (MSP142) Vaccines for Plasmodium falciparum MalariaPLoS Clinical Trials, 2007
- Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum MalariaInfection and Immunity, 2005
- Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malariaVaccine, 2005
- In Vitro Studies with RecombinantPlasmodium falciparumApical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic ResponseInfection and Immunity, 2002
- Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISAJournal of Immunological Methods, 1994
- Comparison of an ELISA system for the quantification of hepatitis B antibody with an automated and a semi-automated systemJournal of Virological Methods, 1993
- Increased coating efficiency of antigens and preservation of original antigenic structure after coating in ELISAJournal of Immunological Methods, 1989
- Enzyme immunoassays with special reference to ELISA techniques.Journal of Clinical Pathology, 1978
- Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin GImmunochemistry, 1971
- Immunoassay using antigen—enzyme conjugatesFEBS Letters, 1971